Corcept Therapeutics Stock News & Updates
[WKN: 529882 | Symbol: CORT]
Stocks in Action USA: Garmin, Rocket and Corcept.
Garmin (GRMN) - The wearable specialist focuses on AI in the fitness sector: New subscription platform...
Darvas Screening: DraftKings, Carvana, Corcept Therapeutics, Innodata
DraftKings DraftKings (NASDAQ: DKNG) is a digital sports entertainment and gaming company that offers...
Corcept Therapeutics: Rising Company in the Treatment of Cushing's Syndrome
Corcept Therapeutics is a specialist in cortisol modulation and controls the excess production of the...
Corcept Therapeutics (CORT): Canaccord sees 111% price potential - Phase III data from the ROSELLA study could impress
Corcept Therapeutics Inc. (CORT) is focused on the development of drugs that modulate the effects of...
TOP-5 Price Targets of Analysts on January 30, 2025
Secunet Security Networks [DE0007276503]: Warburg Research reaffirms Buy rating and raises price target...
Corcept Therapeutics: Stress in the Fight Against Stress Hormones
Hope Bearer Against Stress Hormones : With Korlym and Relacorilant, Corcept aims to regulate the stress...
4 Reasons to Consider Investing in Corcept Therapeutics!
Screening for Cushing's syndrome is becoming increasingly common, and the number of patients receiving...
The treatment rates for Cushing's syndrome are rising, bringing more attention to Corcept Therapeutics — the stock is likely to break out of the base at its all-time high soon!
Corcept Therapeutics focuses on the development of medications that regulate cortisol levels. With Korlym,...
- ‹
- 1
- ›